160 related articles for article (PubMed ID: 18457319)
1. [Immunosuppression in kidney transplantation].
Legendre C; Zuber J; Anglicheau D; Le Quintrec M; Martinez F; Mamzer-Bruneel MF; Thervet E
Ann Urol (Paris); 2007 Dec; 41(6):276-84. PubMed ID: 18457319
[TBL] [Abstract][Full Text] [Related]
2. Current trends in immunosuppression.
González Posada JM
Nefrologia; 2006; 26 Suppl 2():3-8. PubMed ID: 17937629
[No Abstract] [Full Text] [Related]
3. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
5. Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.
Heifets M; Saeed MI; Parikh MH; Sierka D; Kumar MS
Drugs Aging; 2004; 21(11):747-56. PubMed ID: 15323580
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressors].
Sánchez-Fructuoso AI
Nefrologia; 2008; 28 Suppl 5():21-5. PubMed ID: 18847416
[TBL] [Abstract][Full Text] [Related]
7. Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
Charpentier B
Transplant Proc; 2001; 33(7-8):3334-6. PubMed ID: 11750425
[No Abstract] [Full Text] [Related]
8. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppression in kidney transplantation].
Balssa L; Bittard H; Kleinclauss F;
Prog Urol; 2011 Apr; 21(4):250-3. PubMed ID: 21482398
[TBL] [Abstract][Full Text] [Related]
10. Update in immunosuppression.
Huizinga R
Nephrol Nurs J; 2002 Jun; 29(3):261-7. PubMed ID: 12164076
[TBL] [Abstract][Full Text] [Related]
11. The evolution and future of immunosuppression in renal transplantation.
Goral S; Helderman JH
Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
[TBL] [Abstract][Full Text] [Related]
12. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
[No Abstract] [Full Text] [Related]
13. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
Nashan B; Light S; Hardie IR; Lin A; Johnson JR
Transplantation; 1999 Jan; 67(1):110-5. PubMed ID: 9921806
[TBL] [Abstract][Full Text] [Related]
14. Monitoring antithymocyte globulin in renal transplantation.
Clark K
Ann R Coll Surg Engl; 1996 Nov; 78(6):536-40. PubMed ID: 8943640
[No Abstract] [Full Text] [Related]
15. Efficacy and Safety of Induction Therapy in Kidney Transplantation: A Network Meta-Analysis.
Hwang SD; Lee JH; Lee SW; Park KM; Kim JK; Kim MJ; Song JH
Transplant Proc; 2018 May; 50(4):987-992. PubMed ID: 29731098
[TBL] [Abstract][Full Text] [Related]
16. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
17. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
Birkeland SA
Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
[TBL] [Abstract][Full Text] [Related]
18. Belatacept for kidney transplant recipients.
Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
[TBL] [Abstract][Full Text] [Related]
19. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
Cai J; Terasaki PI
Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients.
Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Ramachamdra V; Singer GG
Transplant Proc; 1999 May; 31(3B Suppl):16S-18S. PubMed ID: 10330962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
